Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Clinical trial NCT00300781 · COMPLETED

Trial details

NCT number: NCT00300781
Sponsor: Puma Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Neoplasms

Start date: 2006-08-04
Primary completion: 2008-04-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.